日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.

紫杉醇/卡铂+ Galunisertib(一种1型TGF-B受体激酶结构域的小分子抑制剂)治疗新诊断、持续性或复发性子宫或卵巢癌肉瘤患者的可行性IB试验。

Washington C, Dwivedi Shailendra Kumar Dhar, Gunderson-Jackson C, Walker J, Mannel R S, Holman L L, Richardson D L, Neelakantan D, Cohoon A, Ding K, Gatalica Z, Moxley K M, Landrum L M, Rowland M R, Bhattacharya R, Moore K N

[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]

[针对中国多发性骨髓瘤患者治疗相关生活质量量表的开发、信度和效度研究]

Sun, C Y; Cai, Z; Chen, B; Chen, L J; Chen, W M; Ding, K Y; Du, J; Fu, R; Fu, C C; Gao, D; Gao, G X; He, Y J; Hou, J; Jiang, M; Li, F; Li, J; Li, J; Li, Z Y; Liao, A J; Liu, J; Luo, J; Luo, J M; Ma, Y P; Mi, J Q; Niu, T; Peng, H L; Song, Y P; Wang, L Q; Zhan, R; Zhang, X; Hu, Y

[Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research]

【中国慢性淋巴细胞白血病诊疗现状:一项全国多中心调查研究】

Xu, W; Yi, S H; Feng, R; Wang, X; Jin, J; Mi, J Q; Ding, K Y; Yang, W; Niu, T; Wang, S Y; Zhou, K S; Peng, H L; Huang, L; Liu, L H; Ma, J; Luo, J; Su, L P; Bai, O; Liu, L; Li, F; He, P C; Zeng, Y; Gao, D; Jiang, M; Wang, J S; Yao, H X; Qiu, L G; Li, J Y

Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine

单细胞异质性以及乳腺癌骨转移和类器官的演变揭示了精准医疗的治疗靶点

Ding, K; Chen, F; Priedigkeit, N; Brown, D D; Weiss, K; Watters, R; Levine, K M; Heim, T; Li, W; Hooda, J; Lucas, P C; Atkinson, J M; Oesterreich, S; Lee, A V

A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

贝伐珠单抗和卢卡帕尼治疗复发性宫颈癌或子宫内膜癌的II期临床试验

Jackson, C G; Moore, K N; Cantrell, L; Erickson, B K; Duska, L R; Richardson, D L; Landrum, L M; Holman, L L; Walker, J L; Mannel, R S; Moxley, K M; Queimado, L; Cohoon, A; Ding, K; Dockery, L E

PHGDH promotes the proliferation and differentiation of primary chicken myoblasts

PHGDH促进鸡原代成肌细胞增殖分化

L Chen, Y L Wu, H Ding, K Z Xie, T Zhang, G X Zhang, J Y Wang

[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component]

[新诊断的滤泡性淋巴瘤合并弥漫性大B细胞淋巴瘤成分的临床特征和预后]

Lin, Z J; Zha, J; Yi, S H; Li, Z F; Ping, L Y; He, X H; Yu, H F; Zheng, Z; Xu, W; Chen, F L; Xie, Y; Chen, B Y; Zhang, H L; Wang, L; Ding, K Y; Li, W Y; Yang, H Y; Zhao, W L; Qiu, L G; Li, Z M; Song, Y Q; Xu, B

[Differential expression profile of miRNAs in amniotic fluid exosomes from fetuses with Down syndrome].

[唐氏综合征胎儿羊水外泌体中 miRNA 的差异表达谱]

Ding K, Yu L, Huang Z, Zheng H, Yang X, Tian T, Xie R

PARPi after PARPi in epithelial ovarian cancer

上皮性卵巢癌中PARPi治疗后的PARPi治疗

Essel, K G; Behbakht, K; Lai, T; Hand, L; Evans, E; Dvorak, J; Ding, K; Konecny, G; Moore, K N

[Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma]

【49例新诊断原发性中枢神经系统弥漫性大B细胞淋巴瘤的临床特征及预后】

Song, J; Liu, H; Shen, H L; Yue, L Z; Yang, X J; Song, W J; Sun, C Y; Yu, S Z; Ding, K; Wang, Y H; Li, L J; Yu, H; Shao, Y Y; Wang, C M; Yue, S Y; Fu, R